US · Healthcare

Kazia Therapeutics Ltd ADR (KZIA)

Biotechnology

Kazia Therapeutics Ltd ADR (KZIA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for KZIA

P/E ratio

25.00

Kazia Therapeutics Ltd ADR (KZIA) — FAQ

What is KZIA's P/E ratio?

The price-to-earnings (P/E) ratio for Kazia Therapeutics Ltd ADR (KZIA) is 25.00 (data as of 2026-05-23).

Does Kazia Therapeutics Ltd ADR pay a dividend?

Dividend yield is not available in the current snapshot for Kazia Therapeutics Ltd ADR (KZIA). Check the MyAverix Finance app for the latest dividend data.

What sector is Kazia Therapeutics Ltd ADR in?

Kazia Therapeutics Ltd ADR (KZIA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is KZIA listed on?

KZIA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)